The article focuses on the need for oncology nurses to monitor their patients for hypersensitivity reactions (HSRs) to prescribed agents. It mentions that protocols specify the frequency with which vital signs need to be obtained during drug infusion and parameters to report to providers. It also discuss continuing education opportunities to be a great way to understand the latest tactics and procedures for addressing HSRs.